GL1X · GenesisL1 explorer

Research workbench

Phosphotriesterase PTE_A53_7

Analyse Phosphotriesterase PTE_A53_7 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FRZ
Type
protein
Length
666 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Parathion hydrolase
EC
3.1.8.1
UniProt
P0A434
Ligands
E4T, ZN
Pockets
5 · best druggability 0.64

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AParathion hydrolase (EC 3.1.8.1)protein32752% helix, 14% strandP0A434
BParathion hydrolase (EC 3.1.8.1)protein33951% helix, 14% strandP0A434

Ligands and binding sites

  • E4T · 5-methylcyclohexane-1,1,3,3-tetrol · ligand · chains A
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • FMT · Formic acid · additive · 2 copies · chains A, B
  • TRS · 2-amino-2-hydroxymethyl-propane-1,3-diol · additive · chains A
  • P6G · Hexaethylene glycol · additive · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A
  • PGE · Triethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12930.640.8137FMT, ZN, E4T, TRS
23230.640.8037FMT, ZN
31750.630.8432empty
4620.320.7614empty
5600.310.7614empty

Interfaces

1 interface between chains.

  • A–B · 1356 Ų buried · 31 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (additive adduct).

Compared structures

  • 6FRZ · Phosphotriesterase PTE_A53_7 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.